There are plausible mechanisms and research evidence on the direct and indirect, impact of table sugar (sucrose) consumption, in the development of metabolic conditions like TY2DM, CVD, fatty liver, etc. There is high self-awareness about the metabolic effects of consuming an increased amount of table sugar and sugar-sweetened products among consumers.1 Apart from regular table sugars, there are various other types of commercially available calorific sweetening agents that are used to sweeten foods and beverages. Similar to table sugar, there is new evidence of the contributions from ‘other types of […]
read more